Omniscan™, the first non-ionic MRI contrast medium, is registered (MRI brain scan pictured here). This is followed by the registration in 1993 of Visipaque™, a third-generation X-ray contrast medium whose isotonic formulation offers additional safety benefits, especially in high-risk procedures.

< Previous Next >
Key:
  The Radiochemical Centre; Amersham International; Nycomed Amersham; Amersham plc
  Nycomed; Nycomed Amersham Imaging; Amersham Health
  Pharmacia; Pharmacia Biotech; Amersham Pharmacia Biotech; Amersham Biosciences

About us - Investors - Our businesses - News & events - Home

© Amersham plc 2003 - All rights reserved. Legal information